Connection

Ioulia Chatzistamou to Mice

Back to Details
This is a "connection" page, showing publications Ioulia Chatzistamou has written about Mice.
Ioulia Chatzistamou
Connection Strength
0.686
Mice
  1. The Value of Outbred Rodent Models in Cancer Research. Trends Cancer. 2018 07; 4(7):468-471.
    View in: PubMed
    Score: 0.065
  2. Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do? Endocr Relat Cancer. 2016 11; 23(11):C9-C12.
    View in: PubMed
    Score: 0.058
  3. Surgical wounding enhances pro-tumor macrophage responses and accelerates tumor growth and lung metastasis in a triple negative breast cancer mouse model. Physiol Rep. 2022 11; 10(21):e15497.
    View in: PubMed
    Score: 0.022
  4. Sub-chronic oral toxicity screening of quercetin in mice. BMC Complement Med Ther. 2022 Oct 23; 22(1):279.
    View in: PubMed
    Score: 0.022
  5. miR155 deficiency reduces breast tumor burden in the MMTV-PyMT mouse model. Physiol Genomics. 2022 11 01; 54(11):433-442.
    View in: PubMed
    Score: 0.022
  6. Ojeok-san ameliorates visceral and somatic nociception in a mouse model of colitis induced colorectal cancer. PLoS One. 2022; 17(6):e0270338.
    View in: PubMed
    Score: 0.022
  7. Targeting protein-protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model. J Pharmacol Sci. 2022 Jul; 149(3):124-138.
    View in: PubMed
    Score: 0.021
  8. Gluten-free diet exposure prohibits pathobiont expansion and gluten sensitive enteropathy in B cell deficient JH-/- mice. PLoS One. 2022; 17(3):e0264977.
    View in: PubMed
    Score: 0.021
  9. Defective humoral immunity disrupts bile acid homeostasis which promotes inflammatory disease of the small bowel. Nat Commun. 2022 01 26; 13(1):525.
    View in: PubMed
    Score: 0.021
  10. Emodin reduces tumor burden by diminishing M2-like macrophages in colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2022 03 01; 322(3):G383-G395.
    View in: PubMed
    Score: 0.021
  11. Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide. J Cancer Res Clin Oncol. 2001 Nov; 127(11):645-52.
    View in: PubMed
    Score: 0.021
  12. Transcriptomic coordination at hepatic steatosis indicates robust immune cell engagement prior to inflammation. BMC Genomics. 2021 Jun 16; 22(1):454.
    View in: PubMed
    Score: 0.020
  13. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice. J Clin Endocrinol Metab. 2001 May; 86(5):2144-52.
    View in: PubMed
    Score: 0.020
  14. Resilience, plasticity and robustness in gene expression during aging in the brain of outbred deer mice. BMC Genomics. 2021 Apr 21; 22(1):291.
    View in: PubMed
    Score: 0.020
  15. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists. Br J Cancer. 2000 Oct; 83(7):906-13.
    View in: PubMed
    Score: 0.019
  16. Immune and microRNA responses to Helicobacter muridarum infection and indole-3-carbinol during colitis. World J Gastroenterol. 2020 Aug 28; 26(32):4763-4785.
    View in: PubMed
    Score: 0.019
  17. Impact of weight loss and partial weight regain on immune cell and inflammatory markers in adipose tissue in male mice. J Appl Physiol (1985). 2020 10 01; 129(4):909-919.
    View in: PubMed
    Score: 0.019
  18. Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy. Front Immunol. 2019; 10:2484.
    View in: PubMed
    Score: 0.018
  19. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Brain Behav Immun. 2019 08; 80:44-55.
    View in: PubMed
    Score: 0.017
  20. Effects of high fat diet-induced obesity on mammary tumorigenesis in the PyMT/MMTV murine model. Cancer Biol Ther. 2019; 20(4):487-496.
    View in: PubMed
    Score: 0.017
  21. Antibiotic-mediated bacteriome depletion in ApcMin/+ mice is associated with reduction in mucus-producing goblet cells and increased colorectal cancer progression. Cancer Med. 2018 05; 7(5):2003-2012.
    View in: PubMed
    Score: 0.016
  22. Modulation of Pancreatic Islets' Function and Survival During Aging Involves the Differential Regulation of Endoplasmic Reticulum Stress by p21 and CHOP. Antioxid Redox Signal. 2017 08 01; 27(4):185-200.
    View in: PubMed
    Score: 0.015
  23. Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model. Cancer Biol Ther. 2017 02; 18(2):85-93.
    View in: PubMed
    Score: 0.015
  24. Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3. Cancer Lett. 2017 03 28; 389:49-58.
    View in: PubMed
    Score: 0.015
  25. Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes. Pflugers Arch. 2016 11; 468(11-12):1957-1968.
    View in: PubMed
    Score: 0.015
  26. Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice. Aging (Albany NY). 2016 10 07; 8(10):2392-2406.
    View in: PubMed
    Score: 0.015
  27. Weight loss following diet-induced obesity does not alter colon tumorigenesis in the AOM mouse model. Am J Physiol Gastrointest Liver Physiol. 2016 10 01; 311(4):G699-G712.
    View in: PubMed
    Score: 0.014
  28. A CCL8 gradient drives breast cancer cell dissemination. Oncogene. 2016 12 08; 35(49):6309-6318.
    View in: PubMed
    Score: 0.014
  29. MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer. Am J Physiol Gastrointest Liver Physiol. 2016 Mar 15; 310(6):G347-58.
    View in: PubMed
    Score: 0.014
  30. Improvement of chemotherapeutic drug efficacy by endoplasmic reticulum stress. Endocr Relat Cancer. 2015 Apr; 22(2):229-38.
    View in: PubMed
    Score: 0.013
  31. p53 antagonizes the unfolded protein response and inhibits ground glass hepatocyte development during endoplasmic reticulum stress. Exp Biol Med (Maywood). 2012 Oct; 237(10):1173-80.
    View in: PubMed
    Score: 0.011
  32. Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proc Natl Acad Sci U S A. 2010 Oct 26; 107(43):18611-5.
    View in: PubMed
    Score: 0.010
  33. ERp29, an endoplasmic reticulum secretion factor is involved in the growth of breast tumor xenografts. Mol Carcinog. 2008 Nov; 47(11):886-92.
    View in: PubMed
    Score: 0.008
  34. Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors. Hum Mol Genet. 2008 Nov 15; 17(22):3596-600.
    View in: PubMed
    Score: 0.008
  35. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues. Regul Pept. 2006 Sep 11; 136(1-3):105-8.
    View in: PubMed
    Score: 0.007
  36. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res. 2005 Mar 01; 65(5):1627-30.
    View in: PubMed
    Score: 0.006
  37. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc Natl Acad Sci U S A. 2003 Aug 05; 100(16):9512-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.